Gavin P. Robertson

This study identifies GDF-15 as a mechanosensing-regulated driver of melanoma pathogenesis, linking mechanical stress, vascular disorganization, and immune suppression.

This study identifies KS100, a pan-ALDH inhibitor, as effective in reducing ALDH expression and viability of multiple myeloma cells, particularly ALDH+/CD138- stem-like cells, potentially overcoming relapse.

This paper develops a novel BTK inhibitor, KS151, which effectively targets MM stem cell-like cells and enhances the response to chemotherapeutic agents.